BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6388325)

  • 1. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
    Cleland J; Semple P; Hodsman P; Ball S; Ford I; Dargie H
    Am J Med; 1984 Nov; 77(5):880-6. PubMed ID: 6388325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
    Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
    Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
    Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and humoral effects of lower body negative pressure in normal, sodium-replete man during angiotensin-converting enzyme inhibition with captopril.
    Rasmussen S; Hesse B; Bonde-Petersen F; Damkjaer Nielsen M; Christensen NJ; Giese J; Warberg J
    Scand J Clin Lab Invest; 1986 Feb; 46(1):81-8. PubMed ID: 3006218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
    Maslowski AH; Ikram H; Nicholls MG; Espiner EA
    Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
    Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
    Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
    Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Apr; 3(4):1035-43. PubMed ID: 6323565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations.
    Flapan AD; Shaw TR; Edwards CR; Davies E; Williams BC
    Am Heart J; 1992 Nov; 124(5):1270-6. PubMed ID: 1442495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
    Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
    Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
    Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.